Max Robotics — Global Service Robot Directory + US Certification

About

Glenn M. Preminger is a pioneering urologist whose research has fundamentally shaped the management of kidney stone disease and the adoption of robotic surgery. His most impactful contribution is leading the development of the AUA Guideline on Management of Staghorn Calculi (2005, 913 citations), which established evidence-based diagnostic and treatment standards that remain a cornerstone of clinical practice. Preminger also advanced minimally invasive techniques, notably through a multicenter trial (1997, 132 citations) that validated a fluoroscopically controlled cutting balloon catheter for treating ureteral and ureteropelvic junction obstruction, offering a less invasive alternative to open surgery. His work on the economics of robot-assisted radical prostatectomy (2005, 160 citations; 2006, 151 citations) provided critical cost analyses that helped hospitals evaluate the financial viability of robotic platforms. Additionally, he contributed to the development of a novel robot for flexible ureteroscopy (2014, 174 citations), pushing the boundaries of endoscopic surgery. With over 900 citations on his landmark guideline alone, Preminger’s research has had a profound and lasting impact on urological practice, blending clinical innovation with rigorous economic and training considerations to improve patient outcomes.